LINC00525 and colorectal cancer: Herein, it was found that LINC00525 and miR-338-3p reduced the expression of each other by binding, and miR-338-3p overexpression and LINC00525 knockdown inhibited UBE2Q1 protein expression in colorectal cancer cells.